The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA
Authors
Gardner, LoisWarrington, Jessica
Rogan, Jane
Rothwell, Dominic G
Brady, Ged
Dive, Caroline
Kostarelos, K.
Hadjidemetriou, Marilena
Affiliation
Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, AV Hill Building, Manchester, UK.Issue Date
2020
Metadata
Show full item recordAbstract
The spontaneous adsorption of biomolecules onto the surface of nanoparticles (NPs) in complex physiological biofluids has been widely investigated over the last decade. Characterisation of the protein composition of the 'biomolecule corona' has dominated research efforts, whereas other classes of biomolecules, such as nucleic acids, have received no interest. Scarce, speculative statements exist in the literature about the presence of nucleic acids in the biomolecule corona, with no previous studies attempting to describe the contribution of genomic content to the blood-derived NP corona. Herein, we provide the first experimental evidence of the interaction of circulating cell-free DNA (cfDNA) with lipid-based NPs upon their incubation with human plasma samples, obtained from healthy volunteers and ovarian carcinoma patients. Our results also demonstrate an increased amount of detectable cfDNA in patients with cancer. Proteomic analysis of the same biomolecule coronas revealed the presence of histone proteins, suggesting an indirect, nucleosome-mediated NP-cfDNA interaction. The finding of cfDNA as part of the NP corona, offers a previously unreported new scope regarding the chemical composition of the 'biomolecule corona' and opens up new possibilities for the potential exploitation of the biomolecule corona for the enrichment and analysis of blood-circulating nucleic acids.Citation
Gardner L, Warrington J, Rogan J, Rothwell DG, Brady G, Dive C, et al. The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA. Nanoscale Horizons. 2020.Journal
Nanoscale HorizonsDOI
10.1039/d0nh00333fPubMed ID
32853302Additional Links
https://dx.doi.org/10.1039/d0nh00333fType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1039/d0nh00333f
Scopus Count
Collections
Related articles
- The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids.
- Authors: Papafilippou L, Nicolaou A, Kendall AC, Camacho-Muñoz D, Hadjidemetriou M
- Issue date: 2023 Jul 6
- In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
- Authors: Hadjidemetriou M, Al-Ahmady Z, Mazza M, Collins RF, Dawson K, Kostarelos K
- Issue date: 2015 Aug 25
- A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.
- Authors: Hadjidemetriou M, Al-Ahmady Z, Buggio M, Swift J, Kostarelos K
- Issue date: 2019 Jan
- Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
- Authors: Raesch SS, Tenzer S, Storck W, Rurainski A, Selzer D, Ruge CA, Perez-Gil J, Schaefer UF, Lehr CM
- Issue date: 2015 Dec 22
- The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
- Authors: Hadjidemetriou M, McAdam S, Garner G, Thackeray C, Knight D, Smith D, Al-Ahmady Z, Mazza M, Rogan J, Clamp A, Kostarelos K
- Issue date: 2019 Jan